PharmaVOICE has featured Pearl Pathways twice in the last year. In January 2012, Pearl President and CEO, Diana Caldwell, shared her thoughts on the expansion of Pearl’s services to meet the growing needs of their customers. In April 2012, Chief Operating Officer, Gretchen Bowker, was asked for her views on the current state of IRBs. To reads Diana’s thoughts on Pearl’s expansion, click here. To read the IRB article, click here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.
5 Common Errors in the Informed Consent Process
Pearl IRB 2024 Year-End Schedule
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
Improving Exempt Submissions: 7 Tips to Reduce Revision Requests